Molejon, Judith O.

HRN: 22-03-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
CEFUROXIME 500MG (TAB)
11/14/2022
11/21/2022
ORAL
500mg
BID
RMLE
Waiting Final Action 

 Indication:  ProphylaxisEmpirical De-escalation    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes